NeoMatrix, Makers of HALO® Breast Pap Test for Breast Cancer Risk Assessment Announces New Management

IRVINE, Calif.--(BUSINESS WIRE)--NeoMatrix, LLC, a breast health solutions company, today announced a new executive management team. CEO and President, France Dixon Helfer states, “I am excited about repositioning and expanding the NeoMatrix HALO technology platform, which plays an important role in screening for early detection of breast cancer. Our new team is on-board and dedicated to a global launch of this product that can help save women’s lives, and to supporting our current and future physician customers who understand how important HALO is in women’s healthcare. The case studies I’ve heard about from physicians have been humbling and gratifying. I believe HALO represents a solid growth opportunity and our foundation is aligned for success.”